APPLICATION
ANDA211791
TYPE
ANDA
ORIGINAL APPROVAL
2020-01-28
LATEST ACTION
2022-01-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
AZITHROMYCINPrescription
AZITHROMYCIN EQ 250MG BASE · TABLET · ORAL
Approval history
2022-01-13Labeling · Supplement 9 · standardAP
2020-06-04Labeling · Supplement 1 · standardAP
2020-01-28UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.